- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- 8.1 Pathogenic microorganisms and the host
- 8.2 The patient with suspected infection
- 8.3 Immunization
- 8.4 Travel and expedition medicine
- 8.5 Viruses
- 8.6 Bacteria
- 8.6.1 Diphtheria
- 8.6.2 Streptococci and enterococci
- 8.6.3 Pneumococcal infections
- 8.6.4 Staphylococci
- 8.6.5 Meningococcal infections
- 8.6.6 Neisseria gonorrhoeae
- 8.6.7 Enterobacteria and bacterial food poisoning
- 8.6.8 Pseudomonas aeruginosa
- 8.6.9 Typhoid and paratyphoid fevers
- 8.6.10 Intracellular klebsiella infections (donovanosis and rhinoscleroma)
- 8.6.11 Anaerobic bacteria
- 8.6.12 Cholera
- 8.6.13 Haemophilus influenzae
- 8.6.14 <i>Haemophilus ducreyi</i> and chancroid
- 8.6.15 Bordetella infection
- 8.6.16 Melioidosis and glanders
- 8.6.17 Plague: Yersinia pestis
- 8.6.18 Other <i>Yersinia</i> infections: Yersiniosis
- 8.6.19 Pasteurella
- 8.6.20 <i>Francisella tularensis</i> infection
- 8.6.21 Anthrax
- 8.6.22 Brucellosis
- 8.6.23 Tetanus
- 8.6.24 Clostridium difficile
- 8.6.25 Botulism, gas gangrene, and clostridial gastrointestinal infections
- 8.6.26 Tuberculosis
- 8.6.27 Disease caused by environmental mycobacteria
- 8.6.28 Leprosy (Hansen’s disease)
- 8.6.29 Buruli ulcer: <i>Mycobacterium ulcerans</i> infection
- 8.6.30 Actinomycoses
- 8.6.31 Nocardiosis
- 8.6.32 Rat bite fevers (<i>Streptobacillus moniliformis</i> and <i>Spirillum minus</i> infection)
- 8.6.33 Lyme borreliosis
- 8.6.34 Relapsing fevers
- 8.6.35 Leptospirosis
- 8.6.36 Nonvenereal endemic treponematoses: Yaws, endemic syphilis (bejel), and pinta
- 8.6.37 Syphilis
- 8.6.38 Listeriosis
- 8.6.39 Legionellosis and legionnaires’ disease
- 8.6.40 Rickettsioses
- 8.6.41 Scrub typhus
- 8.6.42 <i>Coxiella burnetii</i> infections (Q fever)
- 8.6.43 Bartonellas excluding <i>B. bacilliformis</i>
- 8.6.44 <i>Bartonella bacilliformis</i> infection
- 8.6.45 Chlamydial infections
- 8.6.46 Mycoplasmas
- 8.6.47 A checklist of bacteria associated with infection in humans
- 8.7 Fungi (mycoses)
- 8.8 Protozoa
- 8.9 Nematodes (roundworms)
- 8.10 Cestodes (tapeworms)
- 8.11 Trematodes (flukes)
- 8.12 Nonvenomous arthropods
- 8.13 Pentastomiasis (porocephalosis, linguatulosis/linguatuliasis, or tongue worm infection)
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
Mycoplasmas
- Chapter:
- Mycoplasmas
- Author(s):
Jørgen Skov Jensen
, and David Taylor-Robinson
- DOI:
- 10.1093/med/9780198746690.003.0150
Mycoplasmas are the smallest self-replicating prokaryotes. They are devoid of cell walls, with the plasticity of their outer membrane favouring pleomorphism, although some have a characteristic flask-shaped appearance. Mycoplasmas recovered from humans belong to the genera Mycoplasma (14 species and one candidatus species) and Ureaplasma (two species). They are predominantly found in the respiratory and genital tracts, but sometimes invade the bloodstream and thus gain access to joints and other organs. Diagnosis is made by nucleic acid amplification tests and/or serology. Culture is slow and of limited value in clinical diagnosis. Apart from supportive care, treatment is usually with tetracyclines or macrolides, although an increasing prevalence of macrolide resistance is seen, primarily in Asia. There is no commercially available effective vaccine.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- 8.1 Pathogenic microorganisms and the host
- 8.2 The patient with suspected infection
- 8.3 Immunization
- 8.4 Travel and expedition medicine
- 8.5 Viruses
- 8.6 Bacteria
- 8.6.1 Diphtheria
- 8.6.2 Streptococci and enterococci
- 8.6.3 Pneumococcal infections
- 8.6.4 Staphylococci
- 8.6.5 Meningococcal infections
- 8.6.6 Neisseria gonorrhoeae
- 8.6.7 Enterobacteria and bacterial food poisoning
- 8.6.8 Pseudomonas aeruginosa
- 8.6.9 Typhoid and paratyphoid fevers
- 8.6.10 Intracellular klebsiella infections (donovanosis and rhinoscleroma)
- 8.6.11 Anaerobic bacteria
- 8.6.12 Cholera
- 8.6.13 Haemophilus influenzae
- 8.6.14 <i>Haemophilus ducreyi</i> and chancroid
- 8.6.15 Bordetella infection
- 8.6.16 Melioidosis and glanders
- 8.6.17 Plague: Yersinia pestis
- 8.6.18 Other <i>Yersinia</i> infections: Yersiniosis
- 8.6.19 Pasteurella
- 8.6.20 <i>Francisella tularensis</i> infection
- 8.6.21 Anthrax
- 8.6.22 Brucellosis
- 8.6.23 Tetanus
- 8.6.24 Clostridium difficile
- 8.6.25 Botulism, gas gangrene, and clostridial gastrointestinal infections
- 8.6.26 Tuberculosis
- 8.6.27 Disease caused by environmental mycobacteria
- 8.6.28 Leprosy (Hansen’s disease)
- 8.6.29 Buruli ulcer: <i>Mycobacterium ulcerans</i> infection
- 8.6.30 Actinomycoses
- 8.6.31 Nocardiosis
- 8.6.32 Rat bite fevers (<i>Streptobacillus moniliformis</i> and <i>Spirillum minus</i> infection)
- 8.6.33 Lyme borreliosis
- 8.6.34 Relapsing fevers
- 8.6.35 Leptospirosis
- 8.6.36 Nonvenereal endemic treponematoses: Yaws, endemic syphilis (bejel), and pinta
- 8.6.37 Syphilis
- 8.6.38 Listeriosis
- 8.6.39 Legionellosis and legionnaires’ disease
- 8.6.40 Rickettsioses
- 8.6.41 Scrub typhus
- 8.6.42 <i>Coxiella burnetii</i> infections (Q fever)
- 8.6.43 Bartonellas excluding <i>B. bacilliformis</i>
- 8.6.44 <i>Bartonella bacilliformis</i> infection
- 8.6.45 Chlamydial infections
- 8.6.46 Mycoplasmas
- 8.6.47 A checklist of bacteria associated with infection in humans
- 8.7 Fungi (mycoses)
- 8.8 Protozoa
- 8.9 Nematodes (roundworms)
- 8.10 Cestodes (tapeworms)
- 8.11 Trematodes (flukes)
- 8.12 Nonvenomous arthropods
- 8.13 Pentastomiasis (porocephalosis, linguatulosis/linguatuliasis, or tongue worm infection)
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine